Dashboard
1
Poor Management Efficiency with a low ROCE of 5.59%
- The company has been able to generate a Return on Capital Employed (avg) of 5.59% signifying low profitability per unit of total capital (equity and debt)
2
With a fall in Net Sales of -11.05%, the company declared Very Negative results in Sep 25
3
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.71%
0%
-2.71%
6 Months
0.37%
0%
0.37%
1 Year
-1.82%
0%
-1.82%
2 Years
5.69%
0%
5.69%
3 Years
-19.91%
0%
-19.91%
4 Years
-8.18%
0%
-8.18%
5 Years
-1.64%
0%
-1.64%
Baotou Dongbao Bio-Tech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.50%
EBIT Growth (5y)
30.48%
EBIT to Interest (avg)
19.13
Debt to EBITDA (avg)
0.48
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.40
Tax Ratio
13.34%
Dividend Payout Ratio
17.27%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.59%
ROE (avg)
5.20%
Valuation key factors
Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
1.90
EV to EBIT
44.92
EV to EBITDA
19.96
EV to Capital Employed
1.82
EV to Sales
4.17
PEG Ratio
NA
Dividend Yield
0.47%
ROCE (Latest)
4.06%
ROE (Latest)
4.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
161.00
181.00
-11.05%
Operating Profit (PBDIT) excl Other Income
10.30
42.90
-75.99%
Interest
0.90
1.50
-40.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.50
17.90
-35.75%
Operating Profit Margin (Excl OI)
63.70%
104.50%
-4.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -11.05% vs -3.72% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -35.75% vs -5.79% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
882.60
968.80
-8.90%
Operating Profit (PBDIT) excl Other Income
184.40
220.70
-16.45%
Interest
2.80
5.40
-48.15%
Exceptional Items
0.10
0.40
-75.00%
Consolidate Net Profit
91.30
127.40
-28.34%
Operating Profit Margin (Excl OI)
110.30%
142.60%
-3.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -8.90% vs 3.29% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -28.34% vs 10.40% in Dec 2023
About Baotou Dongbao Bio-Tech Co., Ltd. 
Baotou Dongbao Bio-Tech Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






